Sarepta Therapeutics Balance Sheet
NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sarepta Therapeutics financial position
At the end of fiscal 2025, Sarepta Therapeutics reported total assets of $3.35 billion, down 15.5% from a year earlier against total liabilities of $2.21 billion. Shareholders' equity stood at $1.14 billion, or 34.1% of assets. The company held $801.3 million in cash and equivalents against $829.0 million of debt, a net debt position of $27.7 million.
The current ratio (current assets divided by current liabilities) was 2.32, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.73.
Summary generated from market data by MetaCap's automated system. Methodology
Sarepta Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 801.28M | 1.10B | 428.43M | 966.78M | 2.12B | 1.50B | 835.08M | 370.83M | 599.69M | 122.42M |
| Short-Term Investments | 138.37M | 251.78M | 1.25B | 1.02B | 0 | 435.92M | 289.67M | 803.08M | 479.37M | 195.43M |
| Receivables | 398.23M | 601.99M | 400.33M | 214.63M | 152.99M | 101.34M | 90.88M | 49.04M | 29.47M | 5.23M |
| Inventory | 914.74M | 749.96M | 322.86M | 203.97M | 186.21M | 231.96M | 171.38M | 125.44M | 83.61M | 12.81M |
| Total Current Assets | 2.54B | 3.07B | 2.58B | 2.56B | 2.60B | 2.49B | 1.47B | 1.43B | 1.23B | 373.48M |
| Property, Plant & Equipment | 345.13M | 340.34M | 227.15M | 180.04M | 191.16M | 190.43M | 129.62M | 97.02M | 43.16M | 37.80M |
| Intangible Assets | 28.95M | 26.89M | 29.62M | 7.58M | 14.24M | 13.63M | 12.50M | 11.57M | 14.36M | 8.08M |
| Long-Term Investments | 1.05M | 133.16M | 0 | — | — | — | — | — | 10.00M | — |
| Total Assets | 3.35B | 3.96B | 3.26B | 3.13B | 3.15B | 2.98B | 1.82B | 1.64B | 1.31B | 424.10M |
| Accounts Payable | 280.84M | 214.44M | 164.92M | 95.88M | 76.74M | 111.09M | 68.09M | 33.83M | 8.47M | 29.69M |
| Short-Term Debt | — | 0 | 105.48M | 0 | — | — | — | — | — | — |
| Total Current Liabilities | 1.10B | 731.68M | 653.66M | 619.60M | 452.73M | 416.03M | 264.77M | 173.69M | 88.33M | 75.42M |
| Long-Term Debt | 828.97M | 1.14B | 1.24B | 1.54B | 563.67M | — | — | 420.55M | 431.05M | 17.67M |
| Total Liabilities | 2.21B | 2.44B | 2.41B | 2.74B | 2.22B | 2.22B | 1.00B | 609.80M | 518.75M | 87.41M |
| Shareholders' Equity | 1.14B | 1.53B | 859.34M | 384.95M | 928.01M | 761.76M | 818.19M | 1.03B | 789.22M | 336.69M |
| Retained Earnings | -4.88B | -4.21B | -4.45B | -3.91B | -3.21B | -2.85B | -2.29B | -1.58B | -1.22B | -1.17B |
| Total Debt | 828.97M | 1.14B | 1.34B | 1.54B | 563.67M | — | — | 420.55M | 431.05M | 17.67M |
| Net Cash (Debt) | 110.68M | 217.67M | 332.77M | 445.08M | 1.55B | 1.94B | 1.12B | 753.36M | 648.01M | 300.18M |
| Shares Outstanding | 104.96M | 96.90M | 93.73M | 87.95M | 87.13M | 79.37M | 75.18M | 71.07M | 64.79M | 54.76M |
This table shows 10 annual periods of Sarepta Therapeutics's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SRPT's reporting calendar. What is a balance sheet?